Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorpheniramine for prevention of allergic transfusion reactions
NCT04688736Phase 2Recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Jan 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chlorpheniramine in allergic transfusion reaction (ATR), sponsored by Institute of Hematology and Blood Diseases Hospital. Started Jan 2021; status: recruiting.
02
Drugs
chlorpheniramine
03
Conditions
allergic transfusion reaction (ATR)
Beyond the preview
Go deeper on NCT04688736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04688736.